Not recruitingISRCTN72151939
Pramipexole added to mood stabilisers for treatment-resistant depression in bipolarity
Research studyAges 18+United Kingdom
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- United Kingdom
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust
- Sponsor type
- Non-profit organization
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- United Kingdom
- Age range
- Over 18 Years
- Official registry ID
- ISRCTN72151939
- Official title
Show the full official title
Pramipexole trial for Depression in bipolarity
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust.
Who can participate?
This study is for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
Accessing sexual health care for people with severe mental illness
Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in people with Depression in bipolarity
